Hong-Bin Deng
Overview
Explore the profile of Hong-Bin Deng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
261
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu X, Deng H, Gao K, Liu Y, Wang Y, Zhang G, et al.
Pancreas
. 2023 Apr;
51(10):e115-e116.
PMID: 37099792
No abstract available.
2.
Yu X, Deng H, Liu Y, Qu C, Duan Z, Tong Z, et al.
World J Clin Cases
. 2022 Jan;
9(35):10899-10908.
PMID: 35047600
Background: Decreased serum magnesium (Mg) is commonly seen in critically ill patients. Hypomagnesemia is significantly more frequent in patients with severe acute pancreatitis. Acute kidney injury (AKI) in patients with...
3.
Zeng Q, Wang K, Zhang X, Shi Y, Dou Y, Guo Z, et al.
Bioorg Chem
. 2021 Oct;
117:105432.
PMID: 34678602
Twenty-nine 12 N-substituted aloperine derivatives were synthesized and screened for suppression on PD-L1 expression in H460 cells, as a continuation of our work. Systematic structural modifications led to the identification...
4.
Wang F, Zhao N, Gao G, Deng H, Wang Z, Deng L, et al.
J Cancer Res Clin Oncol
. 2020 Aug;
146(11):2851-2859.
PMID: 32743759
Purpose: TP53/EGFR co-mutation has been reported to affect the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in lung adenocarcinoma (LUAD). However, its impact on survival is...
5.
Deng L, Gao G, Deng H, Wang F, Wang Z, Yang Y
J Cancer Res Clin Oncol
. 2019 Aug;
145(10):2613-2624.
PMID: 31463717
Purpose: To determine the frequency of co-occurring genes in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutation and the predictive effect of co-mutations on the...
6.
Zhang X, Liu Q, Zhang N, Li Q, Liu Z, Li Y, et al.
Eur J Med Chem
. 2018 Mar;
149:45-55.
PMID: 29494844
Preventing filoviruses in the entry stage is an attractive antiviral strategy. Taking aloperine, a Chinese natural herb with an endocyclic skeleton, as the lead, 23 new aloperine derivatives were synthesized...
7.
Wang Y, Pang W, Zeng Q, Deng Z, Fan T, Jiang J, et al.
Eur J Med Chem
. 2017 Nov;
143:1858-1868.
PMID: 29133053
To discover small-molecule cancer immunotherapy candidates through targeting Indoleamine 2,3-dioxygenase 1 (IDO1), twenty-five new berberine (BBR) derivatives defined with substituents on position 3 or 9 were synthesized and examined for...
8.
Wang Y, Liu L, Zeng Q, Fan T, Jiang J, Deng H, et al.
Molecules
. 2017 Jul;
22(8).
PMID: 28749438
Twenty-three new berberine (BBR) analogues defined on substituents of ring D were synthesized and evaluated for their activity for suppression of tumor necrosis factor (TNF)-α-induced nuclear factor (NF)-κB activation. Structure-activity...
9.
Bao Y, Zhao X, Deng H, Lu C, Guo Y, Lu X, et al.
Cell Oncol (Dordr)
. 2016 Mar;
39(4):343-52.
PMID: 27016208
Abstact: Background: Non-small cell lung cancer (NSCLC) patients who do initially respond to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) may eventually develop resistance, which may at least...
10.
Deng L, Deng H, Lu C, Guo Y, Wang D, Yan C, et al.
J Cancer Res Clin Oncol
. 2014 Jul;
140(12):2097-105.
PMID: 24994038
Purposes: Epidermal growth factor receptor (EGFR) and KRAS mutations may predict the outcome of targeted drug therapy and also may be associated with the efficacy of chemotherapy in patients with...